Want to see FR:LBIRD full AI Analyst Report?
Lumibird SA (LBIRD) AI Stock Analysis
Top Page
Lumibird SA
(Paris:LBIRD)
The overall score is driven primarily by solid revenue growth and improving profitability, offset by volatile cash flows and only moderate returns on equity, while a supportive but measured technical uptrend adds a secondary positive factor and a premium valuation limits upside.
Lumibird SA (LBIRD) vs. iShares MSCI France ETF (EWQ)
- Market Cap
- EUR 527.53M
- Dividend Yield
- 1.54%
- Average Volume (3M)
- 29.33K
- Price to Earnings (P/E)
- 38.2
- Beta (1Y)
- 0.50
- Revenue Growth
- 8.13%
- EPS Growth
- 31.36%
- Country
- France
- Employees
- 1,078
- Sector
- General
- Sector Strength
- 55
- Industry
- Hardware, Equipment & Parts
Lumibird SA Business Overview & Revenue Model
Company Description
A global leader, Lumibird S.A. specializes in the development, manufacturing, and distribution of a wide array of laser technologies. Its sophisticated laser products are deployed worldwide across scientific, industrial, and medical sectors. The comp...
How the Company Makes Money
Lumibird makes money primarily by selling photonics hardware and related solutions to customers in industry, defense, and healthcare/life-science markets. Key revenue streams generally include: (1) Product sales of laser sources and laser subsystems—...
Lumibird SA Financial Statement Overview
Summary
Healthy revenue growth and improving profitability in 2025, supported by a solid equity base, but modest returns on equity and volatile cash flows limit confidence in long-term earnings quality.
Income Statement
72PositiveBalance Sheet
65PositiveCash Flow
60Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 236.41M | 228.53M | 210.06M | 206.55M | 194.29M | 162.47M |
| Gross Profit | 157.03M | 146.24M | 16.06M | 128.11M | 15.36M | 18.49M |
| EBITDA | 36.61M | 44.32M | 31.03M | 27.31M | 32.09M | 31.81M |
| Net Income | 14.19M | 14.00M | 5.70M | 7.13M | 11.35M | 13.86M |
Balance Sheet | ||||||
| Total Assets | 434.70M | 428.90M | 429.80M | 405.25M | 372.04M | 347.62M |
| Cash, Cash Equivalents and Short-Term Investments | 58.20M | 61.60M | 71.14M | 56.20M | 61.68M | 97.13M |
| Total Debt | 150.80M | 146.20M | 161.06M | 145.08M | 114.18M | 112.03M |
| Total Liabilities | 226.90M | 222.60M | 231.79M | 211.95M | 178.61M | 166.29M |
| Stockholders Equity | 207.80M | 206.30M | 198.01M | 193.30M | 193.44M | 181.33M |
Cash Flow | ||||||
| Free Cash Flow | 673.00K | 12.64M | 11.41M | -4.89M | -28.02M | 6.47M |
| Operating Cash Flow | 17.43M | 29.00M | 34.37M | 20.67M | 1.43M | 26.57M |
| Investing Cash Flow | -16.93M | -15.90M | -22.84M | -46.15M | -29.34M | -28.63M |
| Financing Cash Flow | -8.07M | -22.16M | 3.39M | 21.69M | -7.89M | 18.20M |
Lumibird SA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LBIRD, the sentiment is Neutral. The current price of 24.05 is above the 20-day moving average (MA) of 23.13, below the 50-day MA of 24.31, and above the 200-day MA of 24.02, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 53.09 is Neutral, neither overbought nor oversold. The STOCH value of 88.78 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:LBIRD.
Lumibird SA Peers Comparison
Overall Rating
FR:DIM69Neutral
FR:LBIRD66Neutral
FR:BIM61Neutral
FR:ALTHE46Neutral
FR:ALMKT45Neutral
FR:ALMDT43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | EUR 21.74B | 66.89 | 7.71% | 0.31% | 3.90% | 22.74% | |
| 66Neutral | EUR 533.70M | 38.17 | 6.85% | 1.54% | 8.13% | 31.36% | |
| 61Neutral | EUR 10.69B | 23.03 | 11.01% | 1.08% | -3.18% | 22.52% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 46Neutral | EUR 51.65M | -6.76 | 453.10% | ― | -16.98% | 20.31% | |
| 45Neutral | EUR 18.94M | 1.53 | -157.72% | ― | 3.38% | ― | |
| 43Neutral | EUR 180.85M | -3.00 | 271.64% | ― | 2.16% | -5.26% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FR:LBIRD | Lumibird SA | 24.05 | 2.40 | 11.09% | |
| FR:BIM | bioMerieux SA | 90.50 | -18.90 | -17.27% | |
| FR:ALMKT | MAUNA KEA TECHNOLOGIES | 0.10 | -0.00 | -1.02% | |
| FR:DIM | Sartorius Stedim Biotech | 223.40 | 23.81 | 11.93% | |
| FR:ALTHE | Theraclion SA | 0.70 | 0.05 | 7.69% | |
| FR:ALMDT | Median Technologies | 3.69 | 0.79 | 27.24% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 30, 2026